Building a Resilient and Equitable Health System in South Africa

By Crystal Lubbe

November 7, 2024

The article titled “DTIC Calls for a Resilient Health System” on the SAnews website highlights the critical need for a resilient health system in South Africa, as emphasised by Deputy Minister of Trade, Industry and Competition, Zuko Godlimpi. He outlines several key points regarding the importance of establishing a robust health system capable of facing various challenges.

Call for a Resilient Health System

Deputy Minister Zuko Godlimpi has made it clear that building a resilient health system is a top priority. He highlighted that this system must be robust enough to withstand healthcare challenges that may arise in the future.

Equitable Access

Deputy Minister stressed the need for equitable access to healthcare. It is vital that all segments of the population have fair and equal opportunities to receive health services, minimizing disparities in healthcare access.

Priorities

The call for a robust healthcare framework includes focusing on several key areas:
Equitable Access: Ensuring that healthcare services are accessible to everyone, especially disadvantaged communities.
Human Resources: Enhancing the development of human resources within the healthcare sector to build a stronger workforce.
Infrastructure and Resources: Upgrading healthcare infrastructure and ensuring access to essential medicines, vaccines, and other health products.
Private Sector Engagement: Engaging the private sector to play an active role in strengthening the health system.

Broader Context

This initiative is part of a broader effort to improve the health system in South Africa. It aligns with the Presidential Health Compact, which aims to strengthen the overall health system, enhance access to healthcare, and prepare for the implementation of the National Health Insurance. Through these measures, the goal remains clear: to build a health system that serves all South Africans effectively.

Reference url

Recent Posts

Risicoverevening Policy Updates: Key Amendments for 2022-2025 Explained

By HEOR Staff Writer

January 27, 2026

On December 9, 2025, the Board of Directors of Zorginstituut Nederland (decision reference 2025027072) approved amendments to the Beleidsregels risicoverevening for 2022, 2023, 2024, and 2025. These changes, published in Staatscourant 2026 nr. 967 on January 19, 2026, correct te...
Latin America Pharma Growth: Boehringer Ingelheim’s Strategic Investments and Trends
Latin America Pharma Growth is surging as a high-growth engine for Boehringer Ingelheim, with double-digit market expansions outpacing mature regions like Europe, according to D...
NICE Endorses Dupilumab for Eosinophilic COPD Treatment

By HEOR Staff Writer

January 26, 2026

NICE Backs Dupilumab Eosinophilic COPD Option Dupilumab eosinophilic COPD treatment gains momentum as the National Institute for Health and Care Excellence (NICE) final draft guidance recommends dupilumab as an add-on maintenance therap...